TechCare Establishes Advisory Board Headed by Leading Scientists and Business Executives in the Field of Personal Care and Cosmetic Products

ROSH HA'AIN, Israel, May 31, 2017 /PRNewswire/ --

TechCare Corp. (OTCQB:TECR), a technology company with a revolutionary platform that uses cold vapor technology for natural health and beauty treatments, today announced it has established an Advisory Board to provide expertise and guidance to the Company as it gears up to launch several innovative products in the personal care and cosmetics industry. The Advisory Board is currently comprised of four members:

Ms. Nava Ravid  

As a marketing executive and CEO at global personal care and cosmetics companies, Ms. Ravid was responsible for launching new products and new product categories for some of the world's largest brands. A skin-care industry expert, she has over 30 years of experience in management, marketing, manufacturing, branding and strategy. While CEO of L'Oreal Israel from 2002 to 2015, she lead over 1,200 employees. Prior to L'Oreal, Ms. Ravid was Deputy General Manager of Revlon Israel. She is the owner and CEO of Skin Test Center and serves as a board member and consultant to several companies. Ms. Ravid has received awards for her economic and humanitarian contributions to society.

Dr. Michael Samish 

Dr. Samish has served in positions including senior research scientist in the field of blood sucking arthropods at Hebrew University of Jerusalem, the U.S. Department of Agriculture, and Rutgers University. His major research includes biological, chemical and alternative control methods for blood sucking arthropods such as lice. He has written, reviewed, and presented over a dozen scientific research papers in peer review journals and book chapters. He is a member of numerous scientific organizations including the Entomological Society of America and the New York Academy of Sciences. Dr. Samish received his Ph.D. from the University of Tel Aviv Faculty of Medicine.

Dr. Uri Stoin  

Dr. Stoin is a chemist, professor and inventor in the field of applied chemistry. He most recently served as Chief Chemist at MOG Green Technologies in Switzerland, where he was a scientific consultant in the area of environmental and applied chemistry. He was previously Assistant Professor at Hebrew University of Jerusalem, where he had received his Ph.D. in Applied Chemistry. Dr. Stoin has twelve patents, mostly in the field of pollutant removal.  He is the author of numerous articles in peer reviewed scientific journals.

Mr. George Pehlivanian 

For more than 25 years, George's interest in, and contribution, to the business sector has paved the way for investments and new collaborations in the fields of the arts, high tech, biotech and wellness.

"Our Advisory Board, comprised of a powerful combination of scientific and business experts, is an important asset for our Company. We are honored that these industry experts have chosen to support TechCare based on the merit and potential of our ground breaking and innovative personal care products," stated TechCare Chairman and CEO, Zvi Yemini.

About TechCare Corp. 

TechCare is a technology company engaged in the design, development and commercialization of an innovative platform utilizing cold vaporization of various natural, plant-based compounds, to enable a wide variety of treatment solutions. Inspired by simple, natural treatments that have been used for generations, TechCare's renowned scientists combine traditional wisdom with innovative, proprietary technology and years of research to create solutions that answer the needs of today's consumers. Products scheduled for commercial launch in 2017 include Novokid and Shine. Novokid is a revolutionary anti-lice technology that eliminates lice with one simple 10 minute treatment with no coming or washing. Novokid is 100% natural and pesticide free. Shine, a haircare product, rejuvenates hair by returning its natural health, shine, body and luster by removing residues left over from other haircare products. Additional products are in development and slated for launch in 2018.

Notice Regarding Forward-Looking Statements  

This communication does not constitute an offer to purchase or exchange or the solicitation of an offer to sell or exchange any securities of the Company. This communication contains certain statements that are neither reported financial results nor other historical information and other statements concerning the Company.

These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, events, products and services and future performance. Forward-looking statements are generally identified by the words "will", "expects", "anticipates", "believes", "intends", "estimates", "target", and similar expressions. These and other information and statements contained in this communication constitute forward-looking statements for purposes of applicable securities laws.

Although management of the Company believes that the expectations reflected in the forward looking statements are reasonable, investors and security holders are cautioned that forward looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Company, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by the forward-looking information and statements, and the Company cannot guarantee future results, levels of activity, performance or achievements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in target markets; the Company's ability to develop new technology and products; effects of competition in the Company's main markets; challenges to or loss of intellectual property rights; ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. The forward-looking statements contained in this communication speak only as of the date of this communication and the Company or its representatives are under no duty, and do not undertake, to update any of the forward-looking statements after this date to conform such statements to actual results, to reflect the occurrence of anticipated results or otherwise except as otherwise required by applicable law or regulations.

Contact:
Shlomi Arbel, COO
+972-3-7503060
[email protected]

SOURCE TechCare Corp